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Background: Although associated with intellectual disability, CDKL5 functions and regulation are poorly understood.
Results: Upon neuronal activation, CDKL5 is dynamically regulated through local synthesis, dephosphorylation, and
degradation.
Conclusion: Neuronal activity and maturation control CDKL5 phosphorylation state and expression.
Significance: This is the first report showing the activity-dependent modulation of CDKL5 in the neuronal periphery, further
linking it to synapse development and plasticity.
Mutations in the X-linked CDKL5 (cyclin-dependent kinase-
like 5) gene have been associated with several forms of neurode-
velopmental disorders, including atypical Rett syndrome,
autism spectrumdisorders, and early infantile epileptic enceph-
alopathy. Accordingly, loss of CDKL5 inmice results in autistic-
like features and impaired neuronal communication. Although
the biological functions of CDKL5 remain largely unknown,
recent pieces of evidence suggest that CDKL5 is involved in neu-
ronal plasticity. Herein, we show that, at all stages of develop-
ment, neuronal depolarization induces a rapid increase in
CDKL5 levels, mostly mediated by extrasomatic synthesis. In
young neurons, this induction is prolonged, whereas in more
mature neurons, NMDA receptor stimulation induces a protein
phosphatase 1-dependent dephosphorylation of CDKL5 that is
mandatory for its proteasome-dependent degradation. As a cor-
ollary, neuronal activity leads to a prolonged induction of
CDKL5 levels in immature neurons but to a short lasting
increase of the kinase inmature neurons. Recent results demon-
strate that many genes associated with autism spectrum disor-
ders are crucial components of the activity-dependent signaling
networks regulating the composition, shape, and strength of the
synapse. Thus, we speculate that CDKL5 deficiency disrupts
activity-dependent signaling and the consequent synapse devel-
opment, maturation, and refinement.
CDKL5 (cyclin-dependent kinase like 5)3 is an X-linked gene
that has been associated with early onset epileptic encephalop-
athies characterized by the onset of intractable epilepsy within
the first weeks of life, severe developmental delay, hypotonia,
and some Rett syndrome-like features (1). CDKL5 encodes a
serine/threonine kinase that is characterized by an N-terminal
catalytic domain and a long C-terminal tail regulating the cat-
alytic activity, subcellular localization, and stability of the pro-
tein (2, 3). In human andmouse, theCDKL5/Cdkl5mRNA and
protein arewidely expressedwith awell recognized enrichment
in brain (4). In mouse brains, CDKL5 is weakly expressed dur-
ing embryogenesis and gets markedly up-regulated during
postnatal development (3, 4); furthermore,Cdkl5 transcription
is regulated by various stimuli, depending on the specific brain
district. Indeed, cocaine treatment of rats significantly reduces
Cdkl5mRNA levels in the striatum but not in the frontal cortex
(5). At the cellular level, CDKL5 is easily detectable in all neu-
ronal compartments, including the nucleus, cytoplasm, and
postsynaptic fraction (6). Loss of function studies have demon-
strated that CDKL5 is required for neurite outgrowth, dendritic
spine development, and excitatory synapse stability (4, 6, 7).
The first Cdkl5 knock-out mouse model is characterized by
motor, social, and anxiety deficits similar to those observed in
other autism and Rett syndrome mouse models; Cdkl5-null
mice display also impaired learning and memory and altered
event-related potentials (8, 9). Deficits were also found in neu-
ral circuit communication and in multiple signaling pathways,
including that of AKT-mammalian target of rapamycin
(mTOR), already linked to MeCP2 and Rett syndrome (10).
Neuronal activity is known to influence dendritic outgrowth,
synaptic maturation, and plasticity. In particular, membrane
depolarization and the subsequent calcium influx trigger a vari-
ety of cellular changes, including post-translational modifica-
tion of synaptic molecules, the induction of localized protein
synthesis within dendrites and gene transcription in the
nucleus. Altogether, these events regulate synaptic function
and the response of neuronal circuits to experience (11). These
neuronal activity-dependentmechanisms are involved in learn-
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ing and memory and adaptive behavioral responses; accord-
ingly, autism spectrum disorders have often been associated
with crucial components of the activity-dependent signaling
networks regulating synaptic maturation and function (12).
Considering that CDKL5 (i) is associated with autism spectrum
disorders; (ii) is required for learning andmemory andneuronal
maturation; (iii) gets transiently phosphorylated upon BDNF
stimulation (4); and (iv) gets excluded from the nucleus upon
extrasynaptic NMDA receptors (NMDAR) activation (13), we
hypothesized that it might be involved in activity-dependent
signaling networks. We therefore investigated how neuronal
activity regulates CDKL5, at both transcriptional and post-
transcriptional levels.
Herein, we show that neuronal depolarization induces
CDKL5 within 5 min through NMDARs and mainly relying on
local protein synthesis. The increase of CDKL5 is transient and
is rapidly followed in mature neurons by its proteasomal deg-
radation. We suggest that this response depends on changes in
the phosphorylation state of CDKL5 and requires the activation
of NMDARs and protein phosphatase 1 (PP1). Indeed, only in
neurons beyond a critical developmental stage, NMDAR acti-
vation induces the dephosphorylation of CDKL5, prompting its
degradation. Eventually, Cdkl5 transcription is activated,
although with slower kinetics, resembling those of immediate
early genes. We speculate that the kinase might be a crucial
component of activity-dependent signaling pathways and,
therefore, might affect synapse development and plasticity.
EXPERIMENTAL PROCEDURES
Mice—Mice (CD1 genetic background) were housed and
treated according to the regulations on mouse welfare and eth-
ics and with the approval of the institutional animal care and
use committee of the University of Insubria.
Antibodies—The following antibodies were used forWestern
blotting and immunofluorescence experiments: rabbit poly-
clonal anti-CDKL5 (Sigma Prestige HPA002847) (6), anti-
CaMKII (Abcam, ab92332), anti-phospho-CaMKII (T286,
Abcam, ab124880), polyclonal rabbit anti-ERK1/2 (Millipore,
06-182), rabbit polyclonal anti-phospho-p44/42 ERK (Thr-
202/Tyr-204; Cell Signaling, 9101), mouse monoclonal
anti-CREB (Cell Signaling, 9104), mouse monoclonal anti-
phospho-CREB (S133; Cell Signaling, 9196), mouse monoclo-
nal anti-neuronal class III--tubulin (clone Tuj1; Covance,
MMS-435P), mouse monoclonal anti-MAP2 (Millipore, anti-
MAP2 cloneAP20), rabbit polyclonal anti-PSD-95 (Cell Signal-
ing, 2507), rabbit monoclonal anti-synapsin 1 (Cell Signaling,
D12G5), mouse monoclonal anti-synaptophysin 1 (Synaptic
Systems, 101011), and rabbit polyclonal anti-H3 (Abcam,
ab1791). HRP-conjugated goat anti-mouse or anti-rabbit sec-
ondary antibodies for Western blotting were purchased from
Thermo Scientific.
Primary Neuronal Cultures and Cell Lines—Primary cortical
and hippocampal cultures were prepared from brains of CD1
mouse embryos at 17 days, considering the day of the vaginal
plug as embryonic day 0, as described previously (3), and plated
on poly-L-lysine-coated dishes at different densities (hip-
pocampal neurons, 16,000 cells/cm2; cortical neurons, 26,000
cells/cm2). After 4 days in vitro (DIV4), cytosine-1--D-arabi-
nofuranoside (Sigma-Aldrich) was added at the final concen-
tration of 2 M to prevent astroglial proliferation. The murine
neuroblastoma cells, Neuro 2a (N2a), were grown inMEM sup-
plemented with 10% fetal bovine serum, penicillin (100 IU/ml),
and streptomycin (100 g/ml) at 37 °C in a humidified 5% CO2
atmosphere.
Treatment of Cultured Cells—Neurons were treated at DIV3,
7, 14–16, and 21 as indicated in the text for 5 min with 50 mM
KCl in KRH (85 mM NaCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 2
mM CaCl2, 25 mM Hepes, pH 7.5, 1.1 mg/ml glucose). Control
cells were incubated in KRH containing 5 mM KCl and 130 mM
NaCl. Longer KCl treatments were performed adding 50mMKCl
(or 50mMNaCl to controls, thusmaintaining theosmotic concen-
tration ofmonovalent cations) directly to themedium.Moreover,
when indicated, KCl-dependent depolarization was preceded by
incubation with EGTA (2 mM, 20 min), U0126 (10 M, 20 min;
Promega), (AP5; 100 M, 30 min; Sigma-Aldrich), CNQX
(6-cyano-7-nitroquinoxaline-2,3-dione disodium salt; 40 M, 30
min; Sigma-Aldrich), cycloheximide (40 M; 30 min; Sigma-Al-
drich), MG132 (50 M; 3 h; Sigma-Aldrich), and actinomycin D
(20g/ml; 30min; Sigma-Aldrich). As phosphatase inhibitors we
used okadaic acid (1 M or 20 nM; 45 min; Sigma-Aldrich),
Na3VO4 (1 mM, 1 h; Sigma-Aldrich), calyculin (100 nM; 45 min;
Sigma-Aldrich), anddeltamethrin (20nM;45min;Sigma-Aldrich).
The efficacyof thephosphatase inhibitorswas verifiedbyWestern
blotting using antibodies against phosphotyrosine (Cell Signaling,
9411) and phosphoserine/phosphothreonine (BD Biosciences,
612548), respectively. Neuronswere also exposed to the following
activators: forskolin (100 M; 5 min; Sigma-Aldrich), NMDA (50
M; 5 min; Sigma-Aldrich), and BDNF (50 g/ml; Pepro Tech;
450-02). Neurons were lysed in Laemmli buffer and processed for
immunoblotting.
Preparation and Treatment of Cortical Slices—CD1 mice
(P2.5–P35) were anesthetized with halothane (Sigma-Aldrich)
and decapitated. The brain was quickly removed and put in
ice-cold cutting solution (125 mM NaCl, 2.5 mM KCl, 1.25 mM
NaH2PO4, 26 mM NaHCO3, 10 mM D-glucose, 2 mM CaCl2, 1
mM MgCl2) saturated with 95% oxygen and 5% CO2 (pH 7.4).
Cortical-subcortical coronal frontal slices (anteriorly to the lat-
eral ventricles) were then cut at a thickness of 200 m with a
Leica VT1000S vibratome and maintained at 32 °C for 30 min
to allow functional recovery and later kept at 25 °C in the same
buffer. Recovered slices were transferred in a perfusion cham-
ber and perfused (1 ml/min) at room temperature for 5 min, 20
min, or 1 h with a gassed (95% 02/5% CO2) solution (1.25 mM
KH2PO4, 1.3 mM MgSO4, 2.5 mM CaCl2, 17.6 mM NaHCO3, 10
mM D-glucose, pH 7.4) containing isomolar low or high [K]
(125 mM NaCl, 3 mM KCl or 98 mM NaCl, 30 mM KCl, respec-
tively) in accordance with a previously published protocol (14).
After perfusion, the slides were rapidly lysed in a potter with
200l of lysis buffer (50mMTris-HCl, pH7.4, 150mMNaCl, 1%
TritonX-100, 2mMEDTA, 1mMDTT, 1mMPMSF, 1mMNaF,
1 mM Na3VO4, phosphatase inhibitor mixture (Roche), and
protease inhibitormixture (Sigma)). The protein content of the
samples was measured using the Bio-Rad Bradford method,
and the samples were processed by immunoblotting.
Electrophysiology—Whole cell voltage or current clamp
recordings were obtained from cultured hippocampal neurons
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at DIV7–DIV19 using a Multiclamp 200B amplifier. Current/
voltage traces were filtered at 2 KHz and acquired at 10 KHz
with a Digidata 1440A interface. During recordings, cells were
bathed in standard bicarbonate-buffered external saline (125
mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 26 mM NaHCO3, 2
mMCaCl2, 1mMMgCl2, 10mMglucose, pH 7.4, after saturation
with 5% CO2, 95%O2) at room temperature. For high K stim-
ulation, amodified external saline was obtained from bicarbon-
ate-buffered external saline by decreasing NaCl to 78.5 mM and
increasing KCl to 50 mM. All solutions were bath-applied at 2
ml/min. Patch pipettes (3–5MOhm final resistance) were filled
with a potassium gluconate-based internal solution (145 mM
potassium gluconate, 6 mM NaCl, 0.2 mM EGTA, 1 mM MgCl2,
4 mM ATP-Mg, 0.4 mM GTP-Na2, pH 7.35).
Propidium Iodide Staining—Cortical slices (100 m) of
mouse brains at different ages were perfusedwith a gassed (95%
02/5%CO2) solution (1.25mMKH2PO4, 1.3mMMgSO4, 2.5mM
CaCl2, 17.6 mMNaHCO3, 10mM D-glucose, pH 7.4) containing
isomolar low or high [K] (125 mM NaCl, 3 mM KCl or 98 mM
NaCl, 30 mM KCl, respectively) for 1 h or to induce necrosis
with 0.5 mM Cd2 for 3 h and subsequently incubated with 2.5
g/ml propidium iodide in KRH (130 mM NaCl, 5 mM KCl, 1.2
mM KH2PO4, 1.2 mM MgSO4, 2 mM CaCl2, 25 mM Hepes, pH
7.5, 1.1 mg/ml glucose) for 15 min on ice. After two washes the
slices were fixed in 4% paraformaldehyde for 1 h on ice, washed
twice with PBS, dehydrated, andmounted formicroscopy anal-
ysis. The images were taken at a Nikon Eclipse Ni microscope
equipped with a Nikon Digital Sight DS-2MBWc camera with
fixed exposure time.
Cultured hippocampal neurons were treated with KCl for 5
min or 3 h or, as controls for cell death,with 0.5mMCd2or 200
M H2O2 for 3 h and washed with ice-cold KRH solution. Sub-
sequently, neurons were incubated for 15 min with 2.5 g/ml
propidium iodide in KRH on ice, washed twice, and fixed with
4% paraformaldehyde. Fixed neurons were immunostained
with anti-synapsin 1 and counterstained with DAPI. Images
were taken with an IN Cell Analyzer 1000 at the ALEMBIC
facility (San Raffaele Scientific Institute, Milan, Italy), and the
percentage of propidium iodide positive neurons with respect
to the total number of neurons (synapsin 1 positive) was calcu-
lated. For each timepoint, an average of 150 cellswere analyzed.
Apoptosis Assays—TUNEL stain was used to analyze the
presence of apoptosis in cortical slices (100 m) perfused with
30 mM KCl (1 h) as described above or as a control with 0.5 mM
Cd2 (3 h). The slices were fixed with 4% paraformaldehyde
as above, and the NeuroTACSTM II in situ apoptosis detec-
tion kit (Trevigen) was used following the manufacturer’s
instructions. Images were taken with an Axio ImagerA2
equipped with an AxioCam MRm camera (Zeiss), keeping a
fixed exposure time.
Somatodendritic Fractionations—High density cortical neu-
rons (100,000/cm2) atDIV16were treated for 5minwith 50mM
KCl (or as control with 50 mM NaCl) at 37 °C, rinsed with
Hanks’ balanced salt solution, and treated for 2minwith papain
(0.1 mg/ml; Sigma-Aldrich) and DNase (50 g/ml; Sigma-Al-
drich) in Hanks’ balanced salt solution at 37 °C. In some exper-
iments, MG132 (50 M) was included to avoid protein degra-
dation. The cultures were then rinsed three times with ice-cold
PBS and covered with 1.5ml/dish (60mm) of an ice-cold buffer
(10mMTris-HCl, pH 7.4, 150mMNaCl, 0.5 mM EGTA, protein
inhibitor cocktail, 1 mM NaF, 1 mM NaVO4, 1 mM PMSF, 0.5
mMDTT) containing 0.35 M sucrose, transposed to a new tube,
and then mixed 1:1 with a similar solution containing 0.8 M
sucrose. The final solution was then passed through a plastic
wide tip to break down the neuronal network. The nuclear-
somatic pellet was isolated after centrifugation at 1500 g for
10 min at 4 °C, whereas the supernatant was further centri-
fuged at 28,000 g for 10min, producing the dendritic pellet
enriched in pre- and postsynaptic structures. At the end the
pellets were resuspended in lysis buffer (50 mM Tris-HCl, pH
7.4, 150 mM NaCl, Nonidet P-40 1%, 1 mM EDTA, 0.5 mM
DTT, protein inhibitor cocktail, 1 mM PMSF) and analyzed
by WB.
Synaptoneurosome Preparation—Synaptoneurosomes were
prepared mainly as described in De Rubeis et al. (15): cortices
from young adult (P30–P35) female mice (CD1) were homog-
enized in 1ml of homogenization buffer (0.32M sucrose, 0.1mM
CaCl2, 1 mM MgCl2, 0.1 mM PMSF) in ice using a Teflon glass
homogenizer. The homogenate was brought to a final sucrose
concentration of 1.25 M by adding 4.66 ml of 2 M sucrose and 2
ml of 0.1 mM CaCl2 solution where after the sample was loaded
into the centrifuge tubes and overlaid first with an equal volume
of 1.0 M sucrose, 0.1 mM CaCl2 solution and thereafter with the
homogenization buffer. The samples were centrifuged at
100,000 rpm for 3 h at 4 °C (Beckman TLA 100.4). The pellet
corresponding to the somatic/nuclear fraction was resus-
pended in 1 ml of resuspension buffer (20 mM Hepes, pH 7.4,
147 mM NaCl, 3 mM KCl, 10 mM glucose, 2 mM MgSO4, 2 mM
CaCl2), whereas the synaptoneurosomes were recovered in the
interphase of the 1.25 M/1 M sucrose fractions and pelleted by
centrifugation at 15,000 g for 10 min at 4 °C and finally resu-
pended in 1ml of resuspension buffer. The synaptoneurosomes
were equilibrated by incubation at 37 °C for 30min before stim-
ulation with 50 mM KCl for 5 min at 37 °C; an isomolar exposi-
tion to NaCl was used as control. In the end, the synaptoneuro-
somes and the somatic/nuclear fraction were analyzed by
Western blotting.
Immunofluorescence—Hippocampal neurons were pro-
cessed for immunofluorescence as previously described (3).
Images were taken with a Nikon Eclipse Ni microscope
equipped with a Nikon Digital Sight DS-2MBWc camera. For
the quantification of CDKL5 induction in dendrites, images
were taken with a Leica TCS SP2 confocal microscope
(ALEMBIC, San Raffaele Scientific Institute). Image analysis
was performedwith ImageJ software: theMAP2 signalwas used
to select the dendritic profile excluding the soma, and the cor-
responding CDKL5 fluorescence intensity was quantified.
Western Blot Analysis—Approximately 10 g of protein
extracts were heated (at 70 °C to preserve phosphorylation,
otherwise at 95 °C) and separated by 8% SDS-PAGE (37.5:1
acrylamide:bis-acrylamide) using Tuj1 as internal standard. To
enhance the separation of phosphorylated and nonphosphory-
lated CDKL5 isoforms, we exploited 7% SDS-PAGE with 77:1
acrylamide:bis-acrylamide. Filters were developed using Super-
Signal West Pico Chemiluminescent Substrate (Pierce) or ECL
PrimeWestern blotting detection reagent (GEHealthcare) and
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quantified with a CCD camera (Syngene, G-Box Chemi XRQ)
where each sample wasmeasured relative to the background or
by scanning densitometry using the QuantityOne software
package (Bio-Rad). To evaluate the phosphorylation status, a
ratio between the normalized phospho-protein and the nor-
malized total isoforms of the same protein was calculated.
In Vitro Dephosphorylation Assay—Hippocampal DIV7 neu-
rons were collected directly in lysis buffer (50mMTris-HCl, pH
8, 1 mM EDTA, 150 mM NaCl, 0.5 mM DTT, SDS 0,1%, protein
inhibitor cocktail, 1 mM PMSF, Nonidet P-40 1%) with or with-
out phosphatase inhibitors (1mMNaF, 1mMNaVO4, phospha-
tase inhibitor mixture (Roche)). The protein extract was incu-
bated with or without 800 units of -phosphatase (New England
BioLabs) in a phosphatase reaction buffer (50 mM Tris-HCl, 5
mM DTT, 0.1 mM EDTA, 0.01% Brij 35, pH 7.5), supplemented
with 2 mM MnCl2 for 3 h at 30 °C. The reactions were stopped
by incubation at 65 °C for 15 min, and the samples were ana-
lyzed by immunoblotting.
RNA Isolation and Quantitative RT-PCR Analysis—Total
RNA was isolated using the miRNeasy Kit (Qiagen) according
to the manufacturer’s instructions. Contaminating DNA was
removed with RQ1 RNase-free DNase (Promega), and the
obtained RNA was quantified with a Biotech Ultrospec 2000
UV-visible spectrophotometer, and its quality was assessed
through agarose gel electrophoresis. cDNA was synthetized
from 200 ng of RNA using the SuperScript II reverse transcrip-
tase kit (Invitrogen) as indicated by the manufacturers. Quan-
titative real time PCR was performed with a Chromo 4TM
detector real timePCRmachinewithGoTaqquantitative PCR
Master Mix (Promega). The quantitative RT-PCR was per-
formed in 25 l using 10 ng of cDNA and the following cycling
parameters: 15 s at 95 °C, 30 s at 60 °C, and 30 s at 72 °C. Each
independent sample was analyzed in triplicate from RNA col-
lected from at least three independent neuronal cultures. All
quantitative RT-PCR values were normalized to GAPDH. A
melting curve was automatically generated for each sample and
confirmed that a single amplicon was generated in each
reaction.
Total RNA was extracted from the synaptoneurosomes and
the nuclear-somatic fraction using the miRNeasy kit (Qiagen)
according to the manufacturer’s instructions. After retrotrans-
cription, the presence of Cdkl5 mRNA, along with those of
Mecp2 and Bdnf were analyzed by PCR. The PCRs were per-
formed in 20 l using 50 ng of cDNA and the following cycling
parameters: Cdkl5, 35 cycles: 1 min at 95 °C, 30 s at 50 °C, 1.5
min at 72 °C; Mecp2 mRNA, 35 cycles: 30 s at 94 °C, 30 s at
63 °C, 30 s at 72 °C; and BdnfmRNA, 35 cycles: 30 s at 95 °C, 1
min at 60 °C, 1 min at 72 °C. The forward (F) and reverse (R)
primers were: mCdkl5 F, 5-TTCCCAGCTGTTAACCATCC;
mCdkl5 R, 5-AAGGAGACCGGTCCAAAAGT; c-Fos F, 5-
GGCAAAGTAGAGCAGCTATCTCCT; c-Fos R, 5-TCAGCT-
CCCTCCTCCGATTC; mGapdh F, 5-AAGGTCGGTGTGAA-
CGGATTTG; mGapdh R, 5-GCAGTGATGGCATGGACT-
GTG; mBdnf F, 5-AAGTCTGCATTACATTCCTCGA;
mBdnf R, 5-TTATCAATTCACAATTAAAGCAGCAT; and
mMeCP2 F, 5-CAGCTCCAACAGGATTCCAT; mMeCP2 R,
5-TTGTAGTGGCTCATGCTTGC.
Statistical Analysis—All values are expressed as the average
of at least three different experiments S.E. The significance of
results was evaluated by Student’s t test, one-way analysis of
variance-Dunnett, or two-way analysis of variance test (Bonfer-
roni post hoc analysis), and statistical significance was estab-
lished as p 0.05.
RESULTS
Neuronal Activation Triggers a Rapid, Protein Synthesis-de-
pendent Increase in CDKL5 Levels—As described in the intro-
duction, CDKL5 might play a pivotal role in converting the
effects of transient neuronal stimuli into changes in the molec-
ular pathways that are important for the brain to process infor-
mation. To analyze whether CDKL5 expression might be
affected by neuronal membrane depolarization and in analogy
with several studies based on long and short KCl treatments as
a paradigm for neuronal activation (16, 17), we treated primary
hippocampal neurons, prepared from embryonic day 17mouse
embryos and cultured for in vitro for 7 days, with KCl (50 mM)
for 5 min. Neuronal activation was confirmed by WB, using
phospho-specific antibodies against CaMKII (T286), CREB
(S133), and ERK1/2 (Thr-202 and Tyr-204), respectively, with
respect to total protein levels (Fig. 1A). Neuronal viability was
assessed by current clamp or voltage clamp whole cell record-
ings in which the recovery of spiking activity during KCl-in-
duced depolarization block was verified (Fig. 2, A–C) together
with the presence of spontaneous postsynaptic potentials or
currents with frequency similar to the control (Fig. 2D). As
further controls, we used propidium iodide staining to verify
that short or prolonged treatments with KCl are not toxic to
neuronal cultures at different maturation stages (Fig. 2E).
The response of CDKL5 to neuronal depolarization was ana-
lyzed by using a specific antibody (6), and as shown in Fig. 1 (B
and C), CDKL5 levels significantly increased after 5 min of
treatment; as expected, no increment could be detected in the
protein levels of ERK1/2 and c-Fos (Fig. 1C and data not
shown). To confirm the KCl-dependent induction in an ex vivo
model, cortical slices from young adult mice (P30–P35) were
stimulated with KCl (30 mM) for 5 min. As shown in Fig. 1 (D
andE),WB analyses confirmed that CDKL5 levels are promptly
increased in response to membrane depolarization also in a
complex neuronal network. As before, we controlled the toxic-
ity of short and long term KCl treatments in brain slices of
different developmental ages by analyzing cell mortality
through propidium iodide staining and DNA fragmentation
through TUNEL assays (Fig. 2, F and G, respectively).
We investigated whether the observed fast increase in
CDKL5 protein levels was regulated at the transcriptional or
translational level. Pretreatment of hippocampal neurons with
the protein synthesis inhibitor cycloheximide (40 M, 30 min)
completely prevented the KCl-induced increase in CDKL5 lev-
els (Fig. 1F). Complementary, real time PCR was employed to
investigate whether membrane depolarization induced Cdkl5
transcription and/or the induction of well known CREB-re-
sponsive immediate early genes, such as Akt1, Egr1,Glur2, and
c-Fos (Ref. 18 and Fig. 1G). Amodest but significant increase in
Cdkl5 transcription was observed in neurons treated with KCl;
this induction was comparable with that observed for the other
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early responsive genes. When transcription was blocked
through actinomycin D treatment (Fig. 1H, upper panel), the
KCl-mediated induction of CDKL5 was nonetheless compara-
ble with that of the control (Fig. 1H, lower panels, compare
lanes b and c with lane a), demonstrating that the activity-de-
pendent CDKL5 increase relies on translation of pre-existing
mRNA.
Synaptic Stimulation Induces the Localized Translation of
CDKL5 mRNA—The subcellular distribution of CDKL5 in the
nuclear and cytoplasmic compartments is modulated by
specific stimuli (13); in the dendrites, the protein colocalizes in
the postsynaptic compartment with PSD-95 (6, 7). Thus, we
employed a biochemical approach to investigate whether the
KCl-dependent induction of CDKL5 occurs in the soma or
whether, in analogy with other factors involved in synaptic
activity, it preferentially occurs in the dendrites (Fig. 3, A–C).
Treated and untreated high density neuronal cultures (DIV16;
see “Experimental Procedures” and Ref. 19) were fractionated,
and two protein extracts were obtained enriched in cell bodies
or dendrites, respectively. The successful fractionationwas ver-
ified byWB (Fig. 3A), which showed the presence of histoneH3
or PSD-95 mainly in the somatic or dendritic fractions, respec-
tively. We found that CDKL5 protein levels increase preferen-
tially in the dendritic fraction uponKCl stimulation,whereas its
levels remain rather constant in the soma (Fig. 3, B and C). We
hypothesized that Cdkl5 mRNA might get translated in the
FIGURE 1. Neuronal depolarization induces CDKL5 expression. A, WB of hippocampal neurons treated at DIV7 with KCl for 5 min. Whole cell lysates
were analyzed for phosphorylated and total CaMKII, CREB, and ERKs. Tuj1 was used as loading control. B, CDKL5 levels were analyzed in neurons treated
as in A, using Tuj1 as a loading control. The asterisk indicates an unspecific band sometimes occurring with anti-CDKL5 and resistant to three specific
shRNAs. C, graph showing the fold increase in CDKL5 and ERK1/2 protein levels in depolarized neurons over basal levels indicated with the dotted line.
D, WB showing CDKL5 levels and ERK1/2 phosphorylation in cortical slices (P30–P35) perfused or not with KCl for 5 min. E, the graph shows the fold
induction of CDKL5 and ERK1/2 protein levels in KCl-treated cortical slices. F, graph showing the fold change in CDKL5 levels in neurons treated for 5min
with KCl after 30 min of pretreatment with cycloheximide (CHX) as indicated. G, graph showing the fold change in mRNA levels of the indicated genes
in KCl-treated DIV7 hippocampal neurons with respect to nontreated cells. H, CDKL5 levels in neurons treated with actinomycin D (Act.D) for 30 min and
thereafter with KCl for 5min as indicated. -Tubulin was used as internal standard. Graphs in C and E–G represent themeans S.E. of n 3 experiments.
*, p  0.05; **, p  0.01; ***, p  0.001.
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FIGURE 2. Viability is maintained in hippocampal neurons and cortical slices upon KCl treatment. A, whole cell current clamp recording from a cultured
hippocampal neuron (DIV19). Membrane potential (Vm) dynamics is shown before, during, and after application of high KCl (50 mM in physiological saline;
equimolar substitution with NaCl) for6.5 min (no injected current). Note that during KCl application, the cell depolarizes to5 mV and spontaneous firing
stops presumably because of depolarization block. After washout, firing resumes with no apparent cellular damage (control,1.5 Hz; 14 min after washout:
2.2 Hz). B and C, two short (6-s) epochs from A are shown at higher time resolution. B, control (* in A); C,14 min after KCl washout (# in A). Note frequent
postsynaptic potentials appearing among spikes. In A–C, spikes are clipped to 0mV.D, voltage clamp recording from another cell (DIV 15) subjected to 5-min
application of 50 mM KCl. Top trace, control; bottom trace, 23 min after start of KCl washout. Excitatory postsynaptic currents occurring at low frequency are
visible in both traces. Similar recordingswere obtained in threemore cells. E, percentage of propidium iodide positive hippocampal neurons at DIV3, 7, 14, and
21 upon treatment with 50 mM KCl for 5 min or 3 h. As control of death induction, neurons were treated with Cd2 (0.5 mM, 3 h) or H2O2 (200 M, 3 h). F,
propidium iodide staining of cortical slices from P2.5, P8, P18, and P30mice upon perfusion for 1 h with 3 mM KCl (control) or 30 mM KCl or to induce necrosis
with 0.5 mM Cd2 for 3 h. Scale bar, 200 m. G, TUNEL assay of cortical slices from P2.5, P11, and P30 mice perfused with 30 mM KCl (1 h) or with 0.5 mM Cd2
(3 h). Scale bar, 20 m. Ctrl, control; NT, not treated.
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neuronal periphery, and we therefore analyzed synaptoneuro-
somes (see “Experimental Procedures”), which are fractions
enriched in isolated functional pre- and postsynaptic terminals,
from adult mouse cortices (P30–P35). The enrichment of
PSD-95 and synaptophysin (SYP1) in the synaptic extract veri-
fied the fractionation, whereas a significant contaminationwith
cell bodies was excluded staining for histone H3 (Fig. 3D). By
RT-PCR, we revealed the presence of Cdkl5mRNA in the syn-
aptoneurosomal fraction together with Bdnf transcripts, used
as positive control; on the contrary, and as expected, we were
unable to reveal the presence ofMecp2 mRNA in this fraction
(Fig. 3E). After 5min of stimulation of synaptoneurosomeswith
KCl, CDKL5 levels were subtly but significantly increased
together with the activation of ERKs, demonstrated by the
increased ratio of phosphorylated to total ERKs (Fig. 3, F and
G). Eventually, the dendritic induction of CDKL5 upon depo-
larization was confirmed also in DIV7 neurons by confocal
microscopy using MAP2 as dendritic marker (Fig. 3H).
Membrane Depolarization Induces Dephosphorylation of
CDKL5 and Its Proteasome-mediated Degradation—Having
demonstrated the depolarization-dependent stimulation of
CDKL5 synthesis, we studied the time course of the induction
and of its maintenance, treating DIV7 neurons with KCl (50
mM) for 0, 5, 20, 40, 60, and 180 min. CDKL5 levels (Fig. 4A)
rapidly increased but subsequently declined, reaching basal lev-
elswithin 20min after stimulation and completely disappearing
after 3 h of treatment. This result was confirmed in a complex
native neuronal network by comparing CDKL5 levels in young
adult (P30–35) cortical slices perfused for 1 h with KCl with
those in unstimulated slices (Fig. 4, B andC). To verify whether
a sustained stimulation is required for the down-regulation of
CDKL5, we treated DIV7 hippocampal neurons for 5 min with
KCl and returned them to basal conditions for 3 or 24 h before
WB analysis. As shown in Fig. 4D, a short stimulation is suffi-
cient to down-regulate CDKL5. However, protein expression
returned to base line levels after 24 h recovery in resting condi-
tions, thus demonstrating that CDKL5 levels are dynamically
tuned in response to neuronal activity.
Because we have previously demonstrated that CDKL5 levels
can be regulated through proteasomal degradation (13, 20), we
tested whether this mechanism is also involved in the observed
down-regulation. DIV7 neurons were incubated with the pro-
teasomal inhibitor MG132 (50 M) prior to KCl induction.
Indeed, the presence of MG132 contained CDKL5 reduction
after sustained KCl treatment (Fig. 4, E and F). As already pro-
posed (13), in the presence of MG132, CDKL5 levels rise in
unstimulated neurons as well, therefore confirming that
CDKL5 turnover is constitutively regulated by proteasomal
degradation.
While we were performing these experiments, we noticed
that, depending on the electrophoretic conditions, CDKL5
shows an increased mobility upon 20 min KCl induction.
Because the migration of some proteins is affected by their
phosphorylation status and protein phosphorylation has fre-
quently been associated with neuronal activation and synaptic
plasticity, we investigated whether CDKL5 phosphorylation is
modulated upon membrane depolarization. As shown in Fig.
5A, after 20min of KCl stimulation and under appropriate elec-
trophoretic conditions (7% SDS-PAGE with 77:1 acrylamide:
bis-acrylamide), CDKL5migratesmainly as a single bandwith a
higher mobility than the prominent band from untreated neu-
rons. We incubated unstimulated or stimulated neuronal
extracts with -phosphatase and confirmed that themobility of
the dephosphorylated kinase is identical to that caused by pro-
longed KCl stimulation, therefore confirming that the acquired
higher mobility is caused by CDKL5 dephosphorylation (Fig.
5B).
We proceeded analyzingwhether a brief stimulationwas suf-
ficient to induce the appearance of the faster isoformofCDKL5.
Neurons were thus depolarized by KCl for 5min and allowed to
recover for another 15 min in resting medium. The brief stim-
ulationwas sufficient to induceCDKL5dephosphorylation that
gets more pronounced upon longer incubation in the resting
medium (Fig. 5C). To reproduce this observation in a more
complex neuronal network, we analyzed the electrophoretic
mobility of CDKL5 from depolarized cortical slices (Fig. 5D). In
immature cortices (P6.5), themobility of CDKL5 is not affected
even after a prolonged depolarization (1 h); on the contrary, at
P11.5 the same stimulus induces the appearance of small
amounts of a faster migrating isoform of CDKL5. At P21 and
P30, CDKL5 dephosphorylation is visible after only a 5-min
pulse of KCl, therefore suggesting that this modification corre-
lates with neuronal maturation. Accordingly, in undifferenti-
ated neuronal cells, such as mouse Neuro 2a, the mobility of
CDKL5 is affected by phosphorylation (Fig. 5E), but prolonged
KCl treatment induces neither its dephosphorylation nor its
degradation (Fig. 5, F and G). Altogether, these data indicate
that only in mature neurons, membrane depolarization is asso-
ciated with a rapid and transient increase in CDKL5 levels fol-
lowed by an event of dephosphorylation; further, they suggest
that in addition to being rapidly synthesized, CDKL5 gets
quickly degraded after neuronal activation.
NMDARs Mediate CDKL5 Induction—As schematized in
Fig. 6A, neuronal activation can induce local protein synthesis
FIGURE 3. CDKL5 is synthesized locally at the level of the synapses. A, the purity of somatic and dendritic fractions of cortical neurons (DIV16) was
confirmed by WB using histone H3 and PSD-95 as somatic and dendritic markers, respectively. B, WB showing CDKL5 levels in somatic and dendritic
fractions from KCl-treated neurons (5 min). C, graph showing the fold change in CDKL5 levels in the soma and dendrites (Dendr.) of KCl-treated neurons
over basal levels (dotted line).D, cortices from P30–P35 brains were fractionated into somatic/nuclear (SN) or synaptic fractions (Syn); the fractionation
quality was confirmed by WB with antibodies against PSD-95, SYP1, and histone H3. E, RNA isolated from synaptoneurosomal and somatic/nuclear
fractions was reverse transcribed and amplified by PCR using primers against Cdkl5,Mecp2, and Bdnf. Controls with no DNA are indicated as “.” F, WB
showing CDKL5 levels and ERK1/2 phosphorylation in synaptoneurosomes obtained in D and stimulated with KCl for 5 min. Asterisk indicates unspecific
band. G, graph showing the fold change in CDKL5 and ERK protein levels (normalized with Tuj1; black bars) and ERK1/2 phosphorylation (normalized
with total ERK1/2 level; light gray bars) in stimulated synaptoneurosomes compared with untreated samples (dark gray bar). H, confocal analysis of
CDKL5 expression (green) in DIV7 neurons treated or not for 5 min with 50 mM KCl. MAP2 (red) was used as dendritic marker. The graph shows the
quantification of the dendritic CDKL5 fluorescence intensity. Scale bar, 10m. Graphs in C and G represent themeans S.E. of n 3 experiments. *, p
0.05; **, p  0.01.
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mainly through NMDARs, AMPARs, or voltage-dependent
calcium channels; thus, we proceeded investigating the up-
stream signals that regulate the activation of CDKL5 protein
synthesis upon membrane depolarization. To block KCl-medi-
ated calcium influx, we pretreated hippocampal cultures with
EGTA and demonstrated that calcium is required to induce
CDKL5 (Fig. 6B). This increase was prevented by blocking
NMDA or AMPA receptors with the specific antagonists AP5
or CNQX, respectively. It is widely accepted that local protein
synthesis requires the activation of ERKs and PKA. Consis-
tently, the KCl-dependent increase in CDKL5 levels was pre-
vented by selectively inhibiting ERKs through preadministra-
tion of U0126. Accordingly, we detected an increase in CDKL5
levels, comparable with that of KCl-stimulated neurons, after
FIGURE 4. Neuronal depolarization induces proteasome-dependent CDKL5 degradation. A, WB and graph showing CDKL5 levels in DIV7 neurons
treatedwith KCl for the indicated time points. The graph shows the fold change in CDKL5 levels at the different time points of KCl treatment with respect
to nontreated neurons (gray bar). Tuj1 was used as loading control. The t test was performed comparing normalized CDKL5 levels at each time point with
those at basal levels. B, CDKL5, phosphorylated, and total ERK1/2 levels in cortical slices (P30–P35) after 1 h of perfusion with 30 mM KCl. C, graph
showing CDKL5 and total ERK1/2 levels in KCl-treated cortical slices compared with the untreated control (gray bar). D, WB of CDKL5 levels in DIV7
neurons treatedwith KCl and lysed immediately or upon recovery in the restingmedium (Rest. med.) for 3 or 24 h. E, CDKL5 levels in DIV7 neurons treated
for 3 h with KCl, for 6 h with MG132, or with both. F, graph showing the fold change in CDKL5 levels in neurons treated as in E. Asterisks above the bars
indicate the statistical significance compared with basal levels (gray bar). Graphs in A, C, and F represent the means S.E. of n 3 experiments. *, p
0.05; **, p  0.01; ***, p  0.001.
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activation of NMDARs by application of NMDA (50 M for 5
min) or of PKA through forskolin treatment (100M for 5 min;
Fig. 6C). In accordancewith the dependence of the ERKs for the
activity-dependent induction of CDKL5, the kinase was signif-
icantly induced after 5 min of treatment with BDNF that leads
to ERK activation through the TrkB receptors (Fig. 6D).
Altogether these experiments suggest that a robust Ca2
influx through the NMDA/AMPA receptors induces the
observed synaptic synthesis of CDKL5. It is interesting to
observe that, in immature neurons (DIV3; see Fig. 8B), the KCl-
induced expression of CDKL5 is calcium-dependent (data not
shown) and maintained in the presence of AP5 and CNQX,
therefore suggesting that it does not rely onNMDARs (Fig. 6E).
Thus, in young neurons, CDKL5 induction appears mediated
by voltage-dependent calcium channels (21); to the best of our
knowledge, this is the first time that such a switch in the
involved intracellular pathways gets proposed.
NMDARs Trigger a PP1-dependent CDKL5 Dephosphory-
lation Coupled to Its Subsequent Degradation—We then inves-
tigated the signals that mediate CDKL5 dephosphorylation in
hippocampal neurons. Dephosphorylation was inhibited by
preventing extracellular calcium entry, via EGTA, or blocking
NMDARs, using AP5; on the contrary, pretreatment of the cul-
tured neurons with CNQX and U0126 did not affect CDKL5
dephosphorylation, indicating that MAP kinases and AMPARs
are not involved in the observed phosphate removal (Fig. 7A).
By incubating hippocampal neurons with NMDA for 20 min,
we further demonstrated that Ca2 influx through NMDARs
triggers CDKL5 dephosphorylation (Fig. 7B). On the contrary,
other stimuli such as forskolin or BDNF, which can rapidly
induce the expression of CDKL5 (Fig. 6, C and D), are not able
to promote its dephosphorylation (Fig. 7C).
Neuronal activation and synaptic plasticity events are medi-
ated by affecting the functions and interactions of a multitude
of proteins, mainly through changes in their phosphorylation
status; thus, phosphatases, in addition to kinases, play a pivotal
role for synaptic plasticity. The majority of these phosphoryla-
tion events occur on serine and threonine residues, and in gen-
eral, the protein phosphatases PP1, PP2A, and calcineurin
(PP2B) are considered the most important dephosphorylating
enzymes (21). To exclude the involvement of tyrosine dephos-
phorylation in the KCl-dependent change of CDKL5 electro-
phoretic mobility, we inhibited tyrosine phosphatases by pre-
treating primary hippocampal neurons with Na3VO4. As
clearly shown in Fig. 7D, even if tyrosine phosphatases were
efficiently inhibited (see “Experimental Procedures”), no inhi-
bition of KCl-dependent CDKL5 dephosphorylation was
observed. Hippocampal neurons were then treated with the
potent calcineurin inhibitor deltamethrin; as shown in Fig. 7E,
the drug does not impede CDKL5 dephosphorylation although
the efficient inhibition was verified (see “Experimental Proce-
dures”). On the contrary, the faster migrating, dephosphory-
lated band is not presentwhen 100 nM calyculinA, which inhib-
its PP1 and PP2A, is administered to neurons, therefore
implying the involvement of either or both enzymes (Fig. 7E).
The presence of 20 nM okadaic acid (OA), which selectively
inhibits PP2A and not PP1 (21), does not impede the KCl-de-
pendent CDKL5 dephosphorylation (Fig. 7F), suggesting the
critical involvement of PP1. Accordingly, 1 M OA, which
inhibits both PP1 and PP2A, impedes the KCl-dependent
CDKL5 dephosphorylation, confirming the pivotal involve-
ment of PP1.
Because the prolonged activation of Neuro 2a cells with KCl
or of neurons with BDNF induces neither the dephosphory-
FIGURE 5. CDKL5 is dephosphorylated upon neuronal depolarization. A, WB showing the mobility of CDKL5 after KCl treatment of hippocampal
neurons (DIV7) for 5 or 20 min. Arrows indicate slow and fast migrating CDKL5 isoforms. B, electrophoretic mobility of CDKL5 in DIV7 hippocampal
neurons treated or not with KCl for 20 min and after incubation of the total cell extract with -phosphatase (-phosphatase) or with the phosphatase
buffer alone for 3 h. C, migration of CDKL5 in extracts from hippocampal neurons treated for 5 min with KCl and lysed immediately or returned to the
resting medium (Rest. med.) for 15 min. D, mobility of CDKL5 in cortical slices at the indicated postnatal stages perfused with KCl for 1 h or 5 min as
indicated. E, electrophoretic mobility of CDKL5 in whole cell lysates of mouse N2a cells and hippocampal neurons at DIV7 treated for 3 h with
-phosphatase or with the buffer alone. F, mobility of CDKL5 in extracts of N2a cells treated or not for 1 h with 50mM KCl. G, graph showing CDKL5 levels
in N2a cells treated for 3 h with or without 50mM KCl. No significant change in CDKL5 levels was observed. The graph represents themeans S.E. of n	
3 experiments. In A–F, the extracts were separated on 7% gels.
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lation nor the degradation of CDKL5 (Figs. 5, F andG, and 7C),
we suggest the existence of a neuronal-specific molecular link
between the activity-dependent dephosphorylation and the
degradation of CDKL5 after membrane depolarization. Conse-
quently, we addressed whether dephosphorylation is required
for CDKL5 demolition. To this purpose, a prolonged depolar-
ization was applied to DIV7 hippocampal neurons pretreated
with MG132, OA, or a combination of both inhibitors, and
CDKL5 levels were estimated byWestern blotting (Fig. 7G). As
before, the proteasome inhibition blocked the degradation
induced by sustained depolarization (compare column d with
column b); of relevance, under these conditions the faster iso-
form of CDKL5 gets accumulated (Fig. 7H). As shown in col-
umn f with respect to column b, PP1/2A inhibition partially
blocks the KCl-induced degradation; in the presence of both
inhibitors and KCl (column h), CDKL5 levels are rescued with-
out any additional effect (CDKL5 levels in columns h and d are
not statistically different), therefore suggesting that the protea-
FIGURE 6. Inmature neurons the induction of CDKL5 is mainlymediated by NMDARs. A, schematic illustration of the signaling pathways activated at the
synapses and leading to local protein synthesis. B, graph andWB showingCDKL5 levels inDIV7 primary hippocampal neurons treatedwith 50mMKCl for 5min
alone or upon pretreatment with EGTA, AP5, CNQX, or U0126. Tuj1 was used as internal standard (n 3, means S.E.). C and D, WB and graphs showing the
fold increase in CDKL5 levels in DIV7 neurons treated for 5min with KCl, NMDA, or forskolin (Forsk., C) and BDNF (D) with respect to basal levels. Tuj1 was used
as internal standard. Asterisk in the WB (C) indicates an unspecific band (n	 4, means S.E.). E, CDKL5 levels in neurons at the indicated DIV treated with KCl
for 5 min in the presence of both CNQX and AP5 (n	 6, means S.E.). *, p 0.05; **, p 0.01; ***, p 0.001. n.s., not significant.
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some and the phosphatase PP1 work in the same pathway.
Eventually, by testing CDKL5 levels in depolarized neurons
pretreatedwith deltamethrin or different concentrations ofOA
(Fig. 7I), we demonstrated that only by blocking PP1, the
enzyme that causes the appearance of the faster migrating
CDKL5 isoform, the kinase degradationwas impeded (compare
lanes c and b). Thus, we suggest thatCDKL5dephosphorylation
by the phosphatase PP1 is mandatory for its subsequent
demolition.
Neuronal Maturation Refines the Mechanisms Controlling
CDKL5 Levels—As already mentioned, CDKL5 levels increase
in response to neuronal maturation (3, 4); further, the protein
activity and its subcellular localization are modulated by neu-
ronal development (13). We thus proceeded investigating
whether the observed modulation of CDKL5 levels depends on
neuronalmaturation (fromDIV3 toDIV21; Fig. 8). To this pur-
pose, aware that the maturation state of cultured neurons
depends on the growth conditions, we characterized our hip-
pocampal neuronal cultures by costaining for the pre- and post-
synaptic markers synapsin 1 and GluR2, respectively (Fig. 8A).
As expected, with both markers DIV3 neurons do not exhibit
dendritic punctae, therefore indicating their immaturity. DIV7
neurons are more progressed in thematuration process but are
still lacking a clear punctated postsynaptic pattern. From
DIV14, the formation of functional synapses between neurons
is proved by the discrete GluR2-positive dendritic punctae jux-
taposed to synapsin 1-positive presynaptic dots. As shown in
Fig. 8 (B and C), the extent of CDKL5 induction appears to
inversely correlate with neuronal maturation, whereas CDKL5
demolition gets progressively faster. Indeed, in young neurons
(DIV3), 5 min of KCl treatment is sufficient to significantly
induce CDKL5 expression; however, the degradation is re-
tarded upon prolonged KCl treatment and is not accompanied
by the appearance of the faster migrating isoform. On the con-
trary, a very brief depolarization of DIV21 (inset in Fig. 8C)
permits visualization of the induction of CDKL5 that at 5min is
alreadymasked by the very rapid degradation. Altogether, these
data reinforce the observation that CDKL5 dephosphorylation
FIGURE7.CDKL5 turnover is regulatedby its activity-dependentdephosphorylation.A,mobility of CDKL5 inDIV7neurons treatedwith KCl (20min) alone
or upon pretreatment as indicated. The arrows indicate the fast and slowmigrating CDKL5 isoforms. B and C, mobility of CDKL5 in extracts of neurons treated
with NMDA, 20 min (B) or with forskolin (Forsk., 3 h) or BDNF (1–3 h; C). D and E, mobility of CDKL5 in neurons pretreated with Na3VO4 (D), deltamethrin (DM),
or calyculin (CA) (E), before 20 min KCl stimulation. F, CDKL5 mobility in neurons pretreated with 20 nM or 1 M OA before 20 min KCl stimulation. G, graph
showingCDKL5 levels after 3 hof KCl stimulationuponpretreatmentwithOA (1M),MG132 (3 h), or both. Statistical significance is indicatedbyasterisks above
the barswhen CDKL5 levels are compared with basal levels (white bar) and by open circleswhen compared with their respective controls (gray bars). H, CDKL5
migration upon 3 h of KCl treatment of neurons with/without pretreatment with MG132. I, graph showing CDKL5 levels in neurons pretreated with OA (1 M
or 20 nM) or deltamethrin, before 3 h of KCl stimulation. Graphs in G and I, n 3, means S.E.; *, p 0.05; **, p 0.01; ***, p 0.001. In all panels, the extracts
were separated on 7% gels. n.s., not significant.
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ensues at a certain maturation stage and suggest that a novel
mechanism of control is imposed on CDKL5 upon neuronal
maturation, permitting the kinase levels to bemore rapidly and
finely tuned. Accordingly, as shown in Fig. 8D, in immature
neurons, CDKL5 levels are only slightly affected by the pro-
teasome system. Interestingly, the differential regulation of
CDKL5 at different developmental stages was recapitulated in a
more complex ex vivo system: a 1-h KCl stimulation is required
in newborn mice to induce CDKL5 expression, whereas at fur-
ther developmental stages, CDKL5 promptly responds to brief
KCl stimulation and undergoes degradation if the stimulus is
prolonged, with a kinetic resembling that observed in cultured
neurons (Fig. 8E).
DISCUSSION
In this study, we reveal that neuronal activation and the con-
sequent calcium influx up-regulates CDKL5 levels within 5min
of stimulation. Although Cdkl5 transcription is induced by
membrane depolarization, localized activation of protein syn-
thesis appears as themainmechanism involved in the observed
up-regulation. In fact, the kinetics of induction of CDKL5 pro-
tein levels is not compatible with its dependence on prior tran-
scription. Moreover, the response occurs predominantly in the
dendritic fraction and can be obtained by depolarizing purified
synaptoneurosomes. In immature neurons, this induction does
not depend on NMDARs, whereas in more mature neurons
AMPARs and NMDARs mediate the KCl-dependent increase
of CDKL5. In addition, the kinetics of the decline of this activa-
tion changes dramatically with neuronal maturation. In fact, in
DIV3neuronsCDKL5 levels remain above the basal ones for 1 h
after KCl stimulation, whereas at further developmental stages
the kinase returns to basal or even lower levels within fewmin-
utes (10 min at DIV14; 20–30 min at DIV7). This suggests that
CDKL5 levels need to be tightly regulated and that both gain
and loss of functions might be detrimental for proper brain
development. Accordingly, duplications in CDKL5 have very
recently been identified in patients with neurologic deficits
(22). The developmental regulation of the response of CDKL5
to neuronal activation is further supported by the fact that the
KCl-mediated depolarization induces the dephosphorylation
of CDKL5 only beyond a certain developmental stage. CDKL5
dephosphorylation depends mostly on PP1 activity, occurs in
soma and dendrites (data not shown), and is mandatory for its
proteasome-dependent degradation. A similar regulation of
phosphorylation, occurring only in mature neurons and
depending on effectors downstream of NMDARs, has already
been described for CREB, a transcription factor that is widely
implicated in synaptic plasticity and memory formation (21).
Dephosphorylation and subsequent proteasomal degradation
is also commonly used for a prompt regulation of protein func-
tions: among others, the levels of the fragile X syndrome-asso-
ciated protein FMRP are controlled at the synapses through a
dephosphorylation-dependent proteasome-mediated degrada-
tion (23).
Recently, Ebert andGreenberg (12) have postulated that net-
works controlling synapse development and functions are of
high relevance for the pathogenesis of autism spectrum disor-
ders. We suggest that CDKL5 might belong to these neuronal
activity-dependent signaling pathways whose full characteriza-
tion should help in understanding themolecular basis of autism
spectrum disorders and in developing future therapies.
Molecular biology supports this hypothesis. Indeed, a link
betweenCDKL5 and spine development and plasticity has been
established demonstrating that the kinase (i) affects neuronal
morphogenesis through cytoskeleton rearrangements (4); (ii) is
localized at excitatory synapses where it contributes to correct
dendritic spine structure and synapse activity (6, 7); (iii) binds
the scaffolding protein PSD-95 (7); and (iv) binds amphiphysin
1, a protein involved in synaptic vesicle endocytosis (24).
Neuronal activity triggers changes in the synapse composi-
tion, shape, and strength. This can be achieved by inducing the
post-translational modification of synaptic molecules, by the
localized synthesis of dendritic proteins, and by altering nuclear
gene expression. Locally activated CDKL5 might phosphory-
late diverse targets therefore affecting spine maturation and
plasticity. For instance, upon neuronal activity, AMPA recep-
tors modify their conductivity through a specific CaMKII-de-
pendent event of phosphorylation (25). Interestingly, CaMKII,
the most studied kinase involved in the regulation of long-term
potentiation (26), is locally synthetized in the postsynaptic
compartment after NMDAR induction (27).
Further, distally transportedmRNAs are bound by a number
of translational inhibitors that impose a repression that has to
be removed locally to permit protein synthesis (28). Fewkinases
have been identified as being locally up-regulated; their enzy-
matic activity can affect receptor cycling and activation, trans-
lation initiation, or elongation or can be relevant to remove
RNA binding repressors or to induce splicing. Thus, in the
future, it will be highly relevant to reveal the proteome and the
phospho-proteome of activated spines devoid of CDKL5. Of
relevance, the vast majority of missense pathogenic muta-
tions localize in the catalytic domain of CDKL5, therefore
confirming the relevance of its kinase activity for proper
brain function (1).
Synaptic stimulation also transmits signals to the nucleus
affecting specific transcription programs. So far, few pieces of
evidence suggest that CDKL5 has a role in regulating gene
FIGURE 8. The response of CDKL5 to depolarization depends on neuronal maturation. A, immunofluorescence of hippocampal neurons at the indicated
DIV with antibodies against the pre- and postsynaptic markers, synapsin 1 (red) or GluR2 (green), respectively. Scale bar, 100 m. B, WB and graphs showing
CDKL5 levels in hippocampal neurons at DIV3 (left panels) and DIV21 (right panels) after treatment with KCl for the indicated time points. Tuj1 was used as
loadingcontrol.Asterisk in theWB indicates anunspecific band. The statistical significance (t test)was testedby comparingCDKL5 levels at each timepointwith
basal levels (gray bars).C, graph comparing the changes in CDKL5 levels in neurons atDIV3, 7, 14, and 21 treatedwith KCl as indicated. The expression of CDKL5
at DIV3, 14, and 21 was compared with the expression at DIV7 by using a two-way analysis of variance test (Bonferroni post-tests; n  3); no statistical
significance could be determined at any time point between DIV7 and DIV14. The WB in the small inset shows the change in CDKL5 levels in DIV21 neurons
treatedwithKCl for the indicated timepoints.D, CDKL5 levels inDIV3hippocampal neurons treated for 3hwithKCl, for 6hwithMG132, orwithboth. Thegraph
shows the fold change in CDKL5 levels in treated neurons. n	 3, means S.E. *, p 0.05; **, p 0.01; ***, p 0.001. E, WB and graphs showing CDKL5 levels
in cortical slices at the indicated ages perfused with KCl for 5 min or 1 h. (n 3).
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expression such as its capability to interact with the transcrip-
tional repressor MeCP2 (29), the DNA methyl transferase
DNMT1 (30), and with the nuclear speckles involved in RNA
splicing (31). Considering the soma,we have demonstrated that
neuronal activity first inducesCdkl5 transcriptionwith kinetics
similar to those of immediate early genes and then causes
CDKL5 dephosphorylation and degradation. These results
reinforce the already hypothesized involvement of CDKL5 in
influencing gene expression programs indicating the impor-
tance of defining the transcriptional signature of activated neu-
rons devoid of CDKL5. Therefore, in the future we will investi-
gate which pathways affect the observed regulation of CDKL5
and its possible involvement in synaptic plasticity, particularly
in long-term potentiation and long-term depression.
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